Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange

Core Viewpoint - The listing of the RAIN token on the Kraken cryptocurrency exchange is expected to enhance liquidity and accessibility for participants in the RAIN ecosystem, contributing to improved price discovery and secondary market trading [1][3]. Group 1: Company Overview - Enlivex Therapeutics Ltd. is focused on the late-stage clinical development of Allocetra™, a novel therapy for osteoarthritis, and has adopted a treasury strategy centered on the RAIN token [4]. - RAIN serves as the governance and utility token for a decentralized predictions and options protocol built on the Arbitrum network, allowing users to create and trade markets tied to real-world events [3]. Group 2: Market Context - Kraken, the second-largest U.S.-based cryptocurrency exchange, supports a wide range of digital assets and had a total trading volume exceeding $2 trillion in 2025, making it a significant platform for secondary market trading [2]. - The exchange is known for its strong security, regulatory compliance, and transparency, attracting institutional and professional market participants [2]. Group 3: Clinical Development Focus - Osteoarthritis affects over 32.5 million Americans and more than 300 million individuals globally, with projections indicating that 78 million Americans will have the condition by 2040 [5]. - The burden of osteoarthritis is substantial, leading to over one million hospitalizations annually in the U.S., primarily for total joint replacement, highlighting the critical need for effective treatments [5].